MantaBio Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.5M

  • Investors
  • 1

MantaBio General Information

Description

Developer of a real-time polymerase chain reaction (PCR) platform designed for automated microbial contamination detection for biopharma applications. The company's platform provides fully automated, rapid molecular testing at the point-of-need to detect most pathogens and biological contaminants, improve manufacturing efficiency, and address the unmet market need for rapid microbial contamination testing, enabling manufacturers to reduce downtime, avoid batch loss, and respond quickly when every hour matters.

Contact Information

Website
mantabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 48 Dunham Ridge Road
  • Suite 4900
  • Beverly, MA 01915
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 48 Dunham Ridge Road
  • Suite 4900
  • Beverly, MA 01915
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MantaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 13-May-2025 $2.5M Completed Generating Revenue
To view MantaBio’s complete valuation and funding history, request access »

MantaBio Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

MantaBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250288996-A1 Sample preparation cartridges and apparatuses Pending 15-Jul-2019
US-20220226807-A1 Low-volume systems for sample identification Pending 29-May-2019
US-20260092842-A1 Open-access systems for sample identification Pending 29-May-2019
US-20220244182-A1 Methods for identifying nucleic acids in a sample Inactive 29-Apr-2019
US-20240082838-A1 Nucleic acid extraction and purification cartridges Inactive 15-Jun-2017 B01L3/502746
To view MantaBio’s complete patent history, request access »

MantaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MantaBio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beacon Angels Angel Group
To view MantaBio’s complete investors history, request access »

Ready to get started?

Request a free trial

MantaBio FAQs

  • When was MantaBio founded?

    MantaBio was founded in 2025.

  • Where is MantaBio headquartered?

    MantaBio is headquartered in Beverly, MA.

  • What is the size of MantaBio?

    MantaBio has 8 total employees.

  • What industry is MantaBio in?

    MantaBio’s primary industry is Diagnostic Equipment.

  • Is MantaBio a private or public company?

    MantaBio is a Private company.

  • What is MantaBio’s current revenue?

    The current revenue for MantaBio is .

  • How much funding has MantaBio raised over time?

    MantaBio has raised $2.5M.

  • Who are MantaBio’s investors?

    Beacon Angels has invested in MantaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process